×

 

Shaimaa A. Elrasad MBBS, MSc, MD

Consultant, Nuclear Medicine
Medical Imaging Department

Years of Experience: 16

x SURGEON
★ ★ ★ ★ ★ 5/5
En Ar

Education

Medical School

2006

Bachelor’s Degree in Medicine and Surgery

Cairo University, Egypt

Medical School

2013

Master’s Degree in Nuclear Medicine and Radioisotope

Cairo University, Egypt

Residency

2008 - 2011

Resident, Nuclear Medicine and Radioisotope

Kasr Al Ainy School of Medicine, Cairo University, Egypt

Medical School

2015

Doctorate in Nuclear Medicine

Kasr Al Ainy School of Medicine, Cairo University, Egypt

Membership

  • European Association of nuclear medicine 
  • American thyroid association 
  • Egyptian society of radiology and nuclear medicine

License

  • Saudi Commission for Health Specialties

Work Experience

2020 – Present

Consultant, Nuclear Medicine

International Medical Centre in Jeddah, Saudi Arabia

2019 – 2020

Consultant, Nuclear Medicine

Dr. Soliman Fakeeh Hospital in Jeddah, Saudi Arabia

2015 – 2019

Consultant & Lecture of Nuclear Medicine

Kasr Al Ainy School of Medicine, Cairo University, Egypt

2013 – 2015

Specialist & Assistant Lecture of Nuclear Medicine

Kasr Al Ainy School of Medicine, Cairo University, Egypt

2011 – 2013

Clinical Demonstrator of Nuclear Medicine 

Kasr Al Ainy School of Medicine, Cairo University, Egypt

Achievements & Career Highlights

  • Introduction and installing the PET/CT service in Kasr Alain School of Medicine in 2015
  • Introduction of non-FDG PET/CT tracers in Egypt like 18 18F/68G- PSMA
  • Introduction of new radionuclide therapeutic modalities in the IMC and the whale western area in KSA like 223 radium. 

Publications

  • Elrasad Sh, Abdelhafez YG, AbdelKareem M, Amin R, El-Refaei Sh. The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma. Egyptian Journal of Nuclear Medicine; 9 (2015). 
  • Elrasad Sh, AbdelKareem M, Amin R, Abdelhafez YG, El-Refaei Sh. Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. Egyptian Journal of Nuclear Medicine; 9 (2015). 
  • Elrasad Sh, AbdelKareem M, Amin R, Abdelhafez YG, El-Refaei Sh. Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. Egyptian Journal of Nuclear Medicine; 9 (2015). 

Get the Right Care For You & Your Family